Citadel Advisors
EXAS

Citadel Advisors’s Exact Sciences EXAS Stock Holding History

Citadel Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-277,100
Closed -$28.1M – 13311
2025
Q4 		$28.1M Sell
277,100
-25,900
-9% -$2.08M ﹤0.01% 1973
2025
Q3 		$16.6M Buy
303,000
+38,200
+14% +$1.91M ﹤0.01% 2579
2025
Q2 		$14.1M Sell
264,800
-223,100
-46% -$11.3M ﹤0.01% 2592
2025
Q1 		$21.1M Sell
487,900
-89,600
-16% -$4.54M ﹤0.01% 1980
2024
Q4 		$32.4M Buy
577,500
+81,400
+16% +$5.07M 0.01% 1669
2024
Q3 		$33.8M Buy
496,100
+105,200
+27% +$5.94M 0.01% 1563
2024
Q2 		$16.5M Sell
390,900
-344,300
-47% -$18.9M ﹤0.01% 2199
2024
Q1 		$50.8M Buy
735,200
+475,700
+183% +$30.1M 0.01% 1198
2023
Q4 		$19.2M Buy
259,500
+10,700
+4% +$701K ﹤0.01% 2062
2023
Q3 		$17M Sell
248,800
-32,700
-12% -$2.77M ﹤0.01% 2044
2023
Q2 		$26.4M Buy
281,500
+95,600
+51% +$7.46M 0.01% 1601
2023
Q1 		$12.6M Sell
185,900
-79,900
-30% -$5.14M ﹤0.01% 2495
2022
Q4 		$13.2M Sell
265,800
-89,600
-25% -$3.66M ﹤0.01% 2451
2022
Q3 		$11.5M Buy
355,400
+75,300
+27% +$3.1M ﹤0.01% 2565
2022
Q2 		$11M Sell
280,100
-78,900
-22% -$4.22M ﹤0.01% 2554
2022
Q1 		$25.1M Buy
359,000
+167,800
+88% +$12.3M 0.01% 1728
2021
Q4 		$14.9M Sell
191,200
-103,100
-35% -$9.1M ﹤0.01% 2426
2021
Q3 		$28.1M Buy
294,300
+115,000
+64% +$12.1M 0.01% 1630
2021
Q2 		$22.3M Sell
179,300
-89,100
-33% -$10.6M 0.01% 1948
2021
Q1 		$35.4M Buy
268,400
+18,100
+7% +$2.48M 0.01% 1368
2020
Q4 		$33.2M Buy
250,300
+39,200
+19% +$4.74M 0.01% 1296
2020
Q3 		$21.5M Sell
211,100
-35,800
-14% -$3.09M 0.01% 1511
2020
Q2 		$21.5M Sell
246,900
-39,300
-14% -$3.14M 0.01% 1446
2020
Q1 		$16.6M Sell
286,200
-60,000
-17% -$4.87M 0.01% 1386
2019
Q4 		$32M Buy
346,200
+20,600
+6% +$1.81M 0.01% 1075
2019
Q3 		$29.4M Buy
325,600
+84,100
+35% +$9.58M 0.01% 1139
2019
Q2 		$28.5M Buy
241,500
+9,200
+4% +$927K 0.01% 1111
2019
Q1 		$20.1M Sell
232,300
-63,700
-22% -$5.42M 0.01% 1338
2018
Q4 		$18.7M Buy
296,000
+74,300
+34% +$5.1M 0.01% 1291
2018
Q3 		$17.5M Buy
221,700
+96,900
+78% +$6.32M 0.01% 1519
2018
Q2 		$7.46M Sell
124,800
-24,200
-16% -$1.3M ﹤0.01% 2261
2018
Q1 		$6.01M Sell
149,000
-50,600
-25% -$2.47M ﹤0.01% 2261
2017
Q4 		$10.5M Buy
199,600
+40,700
+26% +$2.17M 0.01% 1690
2017
Q3 		$7.49M Sell
158,900
-31,800
-17% -$1.28M 0.01% 1884
2017
Q2 		$6.75M Sell
190,700
-9,800
-5% -$302K 0.01% 1801
2017
Q1 		$4.74M Buy
200,500
+17,100
+9% +$339K ﹤0.01% 2102
2016
Q4 		$2.45M Sell
183,400
-98,800
-35% -$1.6M ﹤0.01% 2715
2016
Q3 		$5.24M Buy
282,200
+80,200
+40% +$1.41M 0.01% 1933
2016
Q2 		$2.48M Buy
202,000
+114,600
+131% +$863K ﹤0.01% 2512
2016
Q1 		$589K Sell
87,400
-38,100
-30% -$244K ﹤0.01% 4178
2015
Q4 		$1.16M Buy
125,500
+26,300
+27% +$245K ﹤0.01% 3398
2015
Q3 		$1.78M Sell
99,200
-15,800
-14% -$363K ﹤0.01% 3095
2015
Q2 		$3.42M Buy
115,000
+74,200
+182% +$1.86M ﹤0.01% 2440
2015
Q1 		$898K Sell
40,800
-73,200
-64% -$1.86M ﹤0.01% 4065
2014
Q4 		$3.13M Buy
114,000
+21,300
+23% +$518K ﹤0.01% 2439
2014
Q3 		$1.8M Sell
92,700
-19,200
-17% -$352K ﹤0.01% 2971
2014
Q2 		$1.91M Buy
111,900
+43,600
+64% +$600K ﹤0.01% 2767
2014
Q1 		$968K Buy
68,300
+8,700
+15% +$117K ﹤0.01% 3465
2013
Q4 		$697K Sell
59,600
-17,900
-23% -$205K ﹤0.01% 3624
2013
Q3 		$915K Buy
77,500
+30,500
+65% +$391K ﹤0.01% 3198
2013
Q2 		$654K Buy
+47,000
New +$511K ﹤0.01% 3583

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Citadel Advisors's EXAS Position: Q1 2026 in Review

Citadel Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 83,025 shares — an estimated $8.43M sold.

Citadel Advisors first reported a position in EXAS in Q2 2013 and held it in 48 quarters. The position peaked at $229M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Citadel Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 83,025 Exact Sciences shares in Q1 2026, an estimated $8.43M.
  • Citadel Advisors first reported a position in Exact Sciences in Q2 2013 and held it in 48 quarters.
  • Citadel Advisors's Exact Sciences position peaked at $229M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.